Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats

Indian Journal of Experimental Biology

Volumn 47, Issue 11, 2009, Pages 880-892

  Kalonia, Harikesh ^a   Kumar, Puneet ^a   Nehru, Bimla ^b   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Glutathione; Huntington's disease; Mitochondrial dysfunction; MK 801; Oxidative stress; Quinolinic acid; Striatum

Indexed keywords

ANIMALIA; RATTUS;

DIZOCILPINE MALEATE; NEUROPROTECTIVE AGENT; QUINOLINIC ACID;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CORPUS STRIATUM; DRUG EFFECT; MALE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DIZOCILPINE MALEATE; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; QUINOLINIC ACID; RATS; RATS, WISTAR;

EID: 77449159593     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Perez-De La Cruz V, Santamaria A, Integrative hypothesis for Huntington's disease: A brief review of experimental evidence, Physiol Res, 56 (2007) 513.
2. Browne S E, Ferrante R J & Beal M F, Oxidative stress in Huntington's disease, Brain Pathol, 9 (1999) 147.
3. Ellerby L M, Hunting for excitement: NMDA receptors in Huntington's disease, Neuron, 33 (2002) 841.
4. Schwarcz R, Foster A C, French E D, Whetsell Jr W O & Kohler C, Excitotoxic models for neurodegenerativedisorders, Life Sci, 35 (1984) 19.
5. Ferrante R J, Kowall N W, Cipolloni P B, Storey E & Beal M F, Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization, Exp Neurol, 119 (1993) 46.
6. Guidetti P, Schwarcz R, 3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease? Adv Exp Med Biol, 527 (2003) 137.
7. Leavitt B R, Van Raamsdonk J M, Shehadeh J, Fernandes H, Murphy Z, Graham R K, Wellington C L, Raymond L A & Hayden M R, Wild-type huntingtin protects neurons from excitotoxicity, J Neurochem, 96 (2006) 1121.
8. Stone T W, Neuropharmacology of quinolinic and kynurenic acids, Pharmacol Rev, 45 (1993) 309.
9. Heyes M P, Saito K, Crowley J S, Davies L E, Demitrack M A, Der M & Dilling M A, Quinolinic acid and kynurenine pathway metabolism in inflammatory and noninflammatory neurological diseases, Brain, 115 (1992) 1249.
10. Nathanson J A, Scavone C, Scalon C, & McKee M, The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechanism for long-term modulation of cellular activity, Neuron, 14 (1995) 781.
11. Rios C, and Santamaria A, Quinolinic acid is a potent lipid peroxidant in rat brain homogenates, Neurochem Res, 16 (1991) 1139.
12. Santamaría A, Ríos C, MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum, Neurosci Lett, 159 (1993) 51-54.
13. Sti'pek S, Stastny F, Platenik J, Crkovska J & Zima T, The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochem Int, 30 (1997) 233.
14. Wong E H, Kemp J A, Priestley T, Knight A R, Woodruff G N & Iversen L L, The anticonvulsant MK-801 is a potent Nmethyl-D-aspartate antagonist, Proc Natl Acad Sci U S A, 83 (1986) 7104.
15. Foster A C, Gill R, Kemp J A & Woodruff G N, Systemic administration of MK-801 prevents N-methyl-D-aspartateinduced neuronal degeneration in rat brain. Neurosci Lett, 76 (1987) 307.
16. Wise-Faberowski L, Pearlstein R D & Warner D S, NMDA induced apoptosis in mixed neuronal/glial cortical cell cultures: the effects of isoflurane and dizocilpine. J Neurosurg Anesthesiol, 18 (2006) 240.
17. Moyanova S G, Kortenska L V, Mitreva R G, Pashova V D, Ngomba R T & Nicoletti F, Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia, Brain Res, 1153 (2007) 58.
18. Cam E, Yulug B & Ozan E, MK 801: a possible neuroprotective agent by poststroke depression? J Neuropsychiatry Clin Neurosci, 20 (2008) 367.
19. Inan S Y, Aksu F, Influence of sex on the interaction between dizocilpine (MK-801) pretreatment and acute coldrestraint stress in epilepsy susceptibility in an animal study, Gend Med, 5 (2008) 136.
20. Paxinos G, Watson C, The rat brain in stereotaxic coordinates, 6th edition, (Academic Press, San Diego) 2007.
21. rd edition, (Vallabh Prakashan, Delhi) 1999.
22. Wills E D, Mechanism of lipid peroxide formation in animal tissue, Biochem J, 99 (1966) 667.
23. Green L C, Wagner D A, Glgowski J, Skipper P L, Wishnok J S & Tannebaum S R, Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids, Ann Biochem, 126 (1982) 131.
24. Luck H, Catalase In: Bergmeyer HU, editor. Methods of enzyme analysis, New York: Academic Press, (1971) 885.
25. Ellman G L, Tissue sulfhydryl groups, Arch Biochem Biophys, 82 (1959) 70.
26. Zahler W L, Cleland W W, A specific and sensitive assay for disulfides. J Biol Chem, 243 (1968) 716.
27. Kono Y, Generation of superoxide radical during autooxidation of hydroxylamine and an assay of superoxide dismutase. Arch Biochem biophysics, 186 (1978) 189.
28. Lowry O H, Rosenbrough N J, Farr A L & Randal R J, Protein measurement with Folin - Phenol reagent, J Biol Chem, 193 (1951) 265.
29. Berman S B, Hastings T G, Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease, J Neurochem, 73 (1999) 1127.
30. King T E, Howard R L, Preparations and properties of soluble NADH dehydrogenases from cardiac muscle, Methods Enzymol, 10 (1967) 275.
31. King T E, Preparation of succinate dehydrogenase and reconstitution of succinate oxidase, Methods Enzymol, 10 (1967) 322.
32. Mosmann T, Rapid colorimetric assay for cellular growth survival: application to proliferation and cytotoxicity assays, J Immunol Methods, 65 (1983) 55.
33. Wood A M, Bristow D R, N-Methyl-D-aspartate receptor desensitisation is neuroprotective by inhibiting glutamateinduced apoptotic-like death, J Neurochem, 70 (1998) 677.
34. Sottocasa G L, Kuylenstierna B, Ernster L & Bergstrand A, An electron-transport system associated with the outer membrane of liver mitochondria, A biochemical and morphological study, J Cell Biol, 32 (1967) 415.
35. Cabrera J, Reiter R J, Tan D X, Qi W, Sainz R M, Mayo J C, Garcia J J & Kim S J, Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings, Neuropharmacology, (2000) 39 507.
36. Stone T W, Perkins M N, Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS, Eur J Pharmacol, 72 (1981) 411.
37. Bruyn R P, Stoof J C, The quinolinic acid hypothesis in Huntington's chorea, J Neurol Sci, 95 (1990) 29.
38. Foster A C, Vezzani A, French E D & Schwarcz R, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid, Neurosci Lett, 48 (1984) 273.
39. Scattoni M L, Valanzano A, Pezzola A, March Z D, Fusco F R, Popoli P & Calamandrei G, Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease, Behav Brain Res, 176 (2007) 216.
40. Schwarcz R, Whetsell W O Jr & Mangano R M, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain, Science, 219 (1983) 316.
41. Coyle J T, Schwarcz R, Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea, Nature, 263 (1976) 244.
42. McGeer E G, McGeer P L, Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids, Nature, 263 (1976) 517.
43. Tatter S B, Galpern W R, Hoogeveen A T & Isacson O, Effects of striatal excitotoxicity on huntingtin-like immunoreactivity, Neuroreport, 6 (1995) 1125.
44. Schanne F A, Kane A B, Young E E & Farber J L, Calcium dependence of toxic cell death: a final common pathway, Science, 206 (1979) 700.
45. Rothman S M, The neurotoxicity of excitatory amino acids is produced by passive chloride influx, J Neurosci, 5 (1985) 1483.
46. Foster A C, Gill R & Woodruff G N, Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation, J Neurosci, 8 (1988) 4745.
47. Beal M F, Kowall N W, Swartz K J, Ferrante R J & Martin J B, Systemic approaches to modifying quinolinic acid striatal lesions in rats, J Neurosci, 8 (1988) 3901.
48. Roberts T J, Williams S C & Modo M, A pharmacological MRI assessment of dizocilpine (MK-801) in the 3-nitroproprionic acid-lesioned rat, Neurosci Lett, 444 (2008) 42.
49. Beal M F, Ferrante R J, Swartz K J & Kowall N W, Chronic quinolinic acid lesions in rats closely resemble Huntington's disease, J Neurosci, 11 (1991) 1649.
50. Sanberg P R, Calderon S F, Giordano M, Tew J M & Norman A B, The quinolinic acid model of Huntington's disease: locomotor abnormalities, Exp Neurol, 105 (1989) 45.
51. Vazey E M, Chen K, Hughes S M & Connor B, Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease, Exp Neurol, 199 (2006) 384.
52. Borlongan C V, Randall T S, Cahill D W & Sanberg P R, Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test, Brain Res, 676 (1995) 231.
53. Shear D A, Dong J, Gundy C D, Haik-Creguer K L & Dunbar G L, Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease, Prog Neuropsychopharmacol Biol Psychiatry, 22 (1998) 1217.
54. Santamaría A, Salvatierra-Sánchez R, Vázquez-Román B, Santiago-López D, Villeda-Hernández J, Galván-Arzate S, Jiménez-Capdeville M E & Ali S F, Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies, J Neurochem, 86 (2003) 479.
55. Kumar P, Padi S S, Naidu P S & Kumar A, Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioral changes: possible neuroprotective mechanisms, Behav Pharmacol, 17 (2006) 485.
56. Rodríguez-Martínez E, Camacho A, Maldonado P D, Pedraza-Chaverrí J, Santamaría D, Galván-Arzate S & Santamaría A, Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum, Brain Res, 858 (2000) 436.
57. Butterfield D A, Pocernich C B & Drake J, Elevated glutathione as a therapeutic strategy in Alzhiemer's disease, Drug Discovery Research, 56 (2002) 428.
58. Calabrese V, Scapagnini G, Ravagna A, Bella R, Butterfield D A, Calvani M & Pennisi G, Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine, Neurochem Res, 28 (2003) 1321.
59. Picconi B, Passino E, Sgobio C, Bonsi P, Barone I, Ghiglieri V, Pisani A, Bernardi G, Ammassari-Teule M & Calabresi P, Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons, Neurobiol Dis, 22 (2006) 143.
60. Pérez-Severiano F, Rodríguez-Pérez M, Pedraza-Chaverrí J, Maldonado P D, Medina-Campos O N, Ortíz-Plata A & Sánchez-García A, S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats, Neurochem Int, 45 (2004) 1175.
61. Giordano M, Ford L M, Brauckmann J L, Norman A B & Sanberg P R, MK801 prevents quinolinic acid-induced behavioral deficits and neurotoxicity in the striatum, Brain Res Bull, (1990) 24 313-19.
62. Bywood P T, Johnson S M, Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices, Exp Neurol, 179 (2003) 47.
63. Sas K, Robotka H, Toldi J & Vécsei L, Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders, J Neurol Sci, 257 (2007) 221.
64. Ribeiro C A, Grando V, Dutra Filho C S, Wannmacher C M & Wajner M, Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats, J Neurochem, 99 (2006) 1531.
65. Schuck P F, Tonin A, da Costa Ferreira G, Rosa R B, Latini A, Balestro F, Perry M L, Wannmacher C M, de Souza Wyse A T & Wajner M, In vitro effect of quinolinic acid on energy metabolism in brain of young rats, Neurosci Res, 57 (2007) 277.
66. Maharaj H, Maharaj D S & Daya S, Acetylsalicylic acid and acetaminophen protect against oxidative neurotoxicity, Metab Brain Dis, 21 (2006) 189.